Experimental models

Area

Gastrointestinal

Indication

Liver diseases (injury, fibrosis, cirrhosis and cancer)

System

In vivo

Model references

Córdoba-Jover B et al. J Nanobiotechnology. 2019

Liver injury induced by Acetaminophen in mouse and rat

Applications

  • Investigation of signaling pathways and possible therapeutic targets involved in liver injury, inflammation, fibrosis and cancer.
  • Investigation of the therapeutic effects of different nanoparticles and biomaterials (cerium, carbon and polymeric nanoparticles) on liver fibrosis and cancer.
  • Investigation of the therapeutic effects of cell implants and tissue engineering on liver regeneration and fibrosis regression.
  • Selective gene therapy or sh/siRNA gene silencing to macrophages, hepatocytes, and endothelial cells.
  • Lipidomic studies using gas chromatography-mass spectrometry.
  • Study of insulin resistance, obesity and hypertrigliceridemia.
  • Hemodynamic studies (cardiac output, mean arterial and portal pressure).
  • Study of hydrosaline balance, liver and renal function, and excretion.
  • Vascular biology analyses: Angiography, lymphangiography, vascular permeability, retina angiogenesis and vascular casting in mouse and rat.
  • Embryonic vascular assessment in mouse.
  • Vascular casting in mouse and rat
  • Measurement of vascular density in response to anti-angiogenic treatment.

Principal investigators

Wladimiro Jiménez, Pedro Melgar-Lesmes.

Model relevance

The use of these pre-clinical models allows evaluating the possible clinical applicability of new drugs or therapies using novel drugs, functionalized nanoparticles or biomaterials.

Share this post:

Has trobat el model experimental per accelerar la teva recerca?

Contacta amb nosaltres, a través del formulari, i ens posem en contacte amb tu per explicar-te més detalls.






    Utilitzem cookies de tercers amb finalitats tècniques i analítiques. Si continua navegant vol dir que accepta la nostra política de cookies. Més informació,plugin cookies política de cookies.

    ACEPTAR
    Aviso de cookies